Mesalamine Capsules for Treatment of Active Ulcerative Colitis: Results of a Controlled Trial

The American Journal of Gastroenterology

Volumn 88, Issue 8, 1993, Pages 1188-1197

  Hanauer, Stephen ^{a,b,c,d,e,f,g}   Schwartz, Jerrold ^{a,b,c,d,e,f,g}   Robinson, Malcolm ^{a,b,c,d,e,f,g}   Roufail, Walter ^{a,b,c,d,e,f,g}   Arora, Sanjeev ^{a,b,c,d,e,f,g}   Cello, John ^{a,b,c,d,e,f,g}   Safdi, Michael ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF CHICAGO   (United States)

^b Northwest Gastroenterologists ^*  (United States)

^c HOSPITAL CORPORATION OF AMERICA   (United States)

^d New England Medical Center ^*  (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f SAN FRANCISCO GENERAL HOSPITAL   (United States)

^g Greater Cincinnati Gastroenterology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG ADMINISTRATION; DRUG CAPSULE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ENTERITIS; FEMALE; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REMISSION; ULCERATIVE COLITIS;

ADULT; AMINOSALICYLIC ACIDS; BIOPSY; CAPSULES; COLITIS, ULCERATIVE; COLON; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MESALAMINE; SIGMOIDOSCOPY; SUPPORT, NON-U.S. GOV'T;

EID: 0027292761     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1993.tb03114.x     Document Type: Article

References (35)

1. Sulfasalazine
2. Sulphasalazine and salicylazosulphadimidine in ulcerative colitis
3. Controlled trial of sulphasalazine in the treatment of ulcerative colitis
4. Sulfasalazine. I. An historical perspective
5. Clinical trials in ulcerative colitis. II. Historical review
6. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis
7. Comparison of cortico‐steroid and sulphasalazine therapy in ulcerative colitis
8. Incidence of sulphasalazine‐induced male infertility
9. Male infertility due of sulphasalazine
10. Male infertility due of sulphasalazine
11. Reversible toxic effect of salicylazosulfapyridine on semen quality
12. Male infertility due to sulphasalazine
13. Male infertility due to sulphasalazine
14. Azulfidine‐induced oligospermia
15. Male infertility due to sulphasalazine
16. An experiment to determine the active therapeutic moiety of sulphasalazine
17. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease
18. Effect of sulphapyridine, 5‐aminosalicytic acid, and placebo in patients with idiopathic proctitis: A study to determine the active therapeutic moiety of sulphasalazine
19. 5‐Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis
20. Coated oral 5‐ami‐nosalicylic acid therapy for mild to moderately active ulcerative colitis: A randomized study
21. Topical and oral aminosalicylates
22. 5‐Aminosalicylic acid in a slow‐release preparation: Bioavailability, plasma level, and excretion in humans
23. Advances in drug therapy for inflammatory bowel disease
24. Analysis of covariance using the rank transformation
25. The “natural history” of ulcerative colitis: An analysis of the placebo response
26. Of mice but not men: Problems of the randomized clinical trial
27. Comparison of delayed release 5‐ aminosalicyclic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse
28. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis: A multicenter study
29. on behalf of an international study group. Coated mesalamine (5‐aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial
30. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: A prospective, randomized, placebo‐controlled, double‐blind, dose‐ranging clinical trial
31. Clinical trial: Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double‐blind study
32. Newer 5‐aminosalicylic acid based drugs in chronic inflammatory bowel disease
33. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype